Ferulic acid suppresses glutamate release through inhibition of voltage-dependent calcium entry in rat cerebrocortical nerve terminals

Journal of Medicinal Food

Volumn 16, Issue 2, 2013, Pages 112-119

  Lin, Tzu Yu ^a,b   Lu, Cheng Wei ^a   Huang, Shu Kuei ^a   Wang, Su Jane ^c,d  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b YUAN ZE UNIVERSITY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

antioxidants; brain; calcium; cerebrocortical nerve terminals; ferulic acid; glutamate release; neuroprotection; phenolic compounds; voltage dependent Ca 2+ channels

Indexed keywords

FERULIC ACID; GLUTAMIC ACID; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKER 4 AMINOPYRIDINE; RYANODINE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DEPOLARIZATION; EXTRACELLULAR CALCIUM; MALE; MITOCHONDRION; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM CALCIUM EXCHANGE; SYNAPTOSOME;

ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; COUMARIC ACIDS; DOWN-REGULATION; GLUTAMIC ACID; MALE; NERVE ENDINGS; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMES;

EID: 84873639633     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.2387     Document Type: Article

References (44)

1. Gohil KJ, Kshirsagar SB, Sahane RS: Ferulic acid-A compre-hesive pharmacology of an important bioflavonoid. IJPSR 2012;3:700-710.
2. Mohmmad Abdul H, Butterfield DA: Protection against amyloid beta-peptide (1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer's disease. Biochim Biophys Acta 2005;1741:140-148. (Pubitemid 40824999)
3. Sultana R, Ravagna A, Mohmmad-Abdul H, Calabrese V, But-terfield DA: Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1-42)- induced oxidative stress and neu-rotoxicity: relationship to antioxidant activity. J Neurochem 2005;92:749-758. (Pubitemid 40229546)
4. Picone P, Bondi ML, Montana G, Bruno A, Pitarresi G, Giam-mona G, Di Carlo M: Ferulic acid inhibits oxidative stress and cell death induced by Ab oligomers: improved delivery by solid lipid nanoparticles. Free Radic Res 2009;43:1133-1145.
5. Zhang Z, Wei T, Hou J, Li G, Yu S, Xin W: Iron-induced oxi-dative damage and apoptosis in cerebellar granule cells: attenuation by tetramethylpyrazine and ferulic acid. Eur J Pharmacol 2003;467:41-47. (Pubitemid 36423383)
6. Joshi G, Perluigi M, Sultana R, Agrippino R, Calabrese V, Butterfield DA: In vivo protection of synaptosomes by ferulic acid ethyl ester (FAEE) from oxidative stress mediated by 2,2-azobis(2-amidino-propane) dihydrochloride (AAPH) or Fe(2+)/H(2)O(2): insight into mechanisms of neuroprotection and relevance to oxidative stress-related neurodegenerative disorders. Neurochem Int 2006;48:318-327. (Pubitemid 43177154)
7. Yu L, Zhang Y, Ma R, Bao L, Fang J, Yu T: Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain. Eur Neuropsycho-pharmacol 2006;16:170-177. (Pubitemid 43358007)
8. Cheng CY, Su SY, Tang NY, Ho TY, Chiang SY, Hsieh CL: Ferulic acid provides neuroprotection against oxidative stress-related apo-ptosis after cerebral ischemia/reperfusion injury by inhibiting ICAM-1 mRNA expression in rats. Brain Res 2008;1209:136-150.
9. Zhao Y, Guan Y, Xu Y, Li Y, Wu W: Sodium ferulate combined with bone marrow stromal cell treatment ameliorating rat brain ischemic injury after stroke. Brain Res 2012;1450:157-165.
10. Yan JJ, Cho JY, Kim HS, Kim KL, Jung JS, Huh SO, Suh HW, Kim YH, Song DK: Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol 2001;133:89-96.
11. Danbolt NC: Glutamate uptake. Prog Neurobiol 2001;65:1-105. (Pubitemid 32479155)
12. Greenamyre JT, Porter RH: Anatomy and physiology of glutamate in the CNS. Neurology 1994;44:S7-S13.
13. Coyle JT, Puttfarcken P: Oxidative stress, glutamate, and neu-rodegenerative disorders. Science 1993;262:689-695. (Pubitemid 23350687)
14. Schinder AF, Olson EC, Spitzer NC, Montal M: Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci 1996;16:6125-6133. (Pubitemid 26313988)
15. Massieu L, Garcia O: The role of excitotoxicity and metabolic failure in the pathogenesis of neurological disorders. Neuro-biology 1998;6:99-108. (Pubitemid 29113099)
16. Meldrum BS: Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 2000;130:1007S-1015S. (Pubitemid 30173635)
17. Raiteri L, Stigliani S, Zappettini S, Mercuri NB, Raiteri M, Bonanno G: Excessive and precocious glutamate release in a mouse model of amyotrophic lateral sclerosis. Neuropharma-cology 2004;46:782-792. (Pubitemid 38368911)
18. Klein J, Mdzinarishvili A, Sambria RK, Lang D: Ginkgo extract EGb761 confers neuroprotection by reduction of glutamate release in ischemic brain. J Pharm Pharm Sci 2012;15:94-102.
19. Niebroj-Dobosz I, Janik P, Kwieciński H: Effect of Riluzole on serum amino acids in patients with amyotrophic lateral sclerosis. Acta Neurol Scand 2002;106:39-43. (Pubitemid 34666577)
20. Wang SJ, Wang KY, Wang WC: Mechanisms underlying the ri-luzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes). Neuroscience 2004;125:191-201.
21. Dunkley PR, Jarvie PE, Heath JW, Kidd GJ, Rostas JA: A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res 1986;372:115-129. (Pubitemid 16024104)
22. 2+ entry and mitogen-activated protein ki-nase signaling pathway. J Agric Food Chem 2010;58:8271-8278.
23. Yang TT, Wang SJ: Pyridoxine inhibits depolarization-evoked glutamate release in nerve terminals from rat cerebral cortex: a possible neuroprotective mechanism? J Pharmacol Exp Ther 2009;331:244-253.
24. 3(5). J Neurochem 1987;48:552-559. (Pubitemid 17005167)
25. 2+ entry preferentially effects protein dephosphorylation, phosphorylation, and glutamate release. J Biol Chem 1992;267:1983-1989.
26. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-3450. (Pubitemid 15114340)
27. 2+ and glutamate release. J Neurochem 1989;53:1693-1699. (Pubitemid 19283636)
28. Barrie AP, Nicholls DG, Sanchez-Prieto J, Sihra TS: An ion channel locus for the protein kinase C potentiation of transmitter glutamate release from guinea pig cerebrocortical synaptosomes. J Neurochem 1991;57:1398-1404. (Pubitemid 21922768)
29. Berridge M J: Neuronal calcium signaling. Neuron 1998;21:13-26. (Pubitemid 28355688)
30. Millan C, Sanchez-Prieto J: Differential coupling of N and P/Q type calcium channels to glutamate exocytosis in the rat cerebral cortex. Neurosci Lett 2002;330:29-32. (Pubitemid 35245762)
31. Vazquez E, Sanchez-Prieto J: Presynaptic modulation of glutamate release targets different calcium channels in rat cere-brocortical nerve terminals. Eur J Neurosc 1997;9:2009-2018. (Pubitemid 27485234)
32. 2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proc Natl Acad Sci USA 1993;90:9518-9522. (Pubitemid 23315816)
33. 2+ channels. Eur J Neurosci 2002; 15:13-18. (Pubitemid 35478005)
34. Sihra TS, Nichols RA: Mechanisms in the regulation of neurotransmitter release from brain nerve terminals: current hypotheses. Neurochem Res 1993;18:47-58. (Pubitemid 23006984)
35. Thompson SM, Capogna M, Scanziani M: Presynaptic inhibition in the hippocampus. Trends Neurosci 1993;16:222-227. (Pubitemid 23139186)
36. Nicholls DG: Presynaptic modulation of glutamate release. Prog Brain Res 1998;116:15-22. (Pubitemid 28526925)
37. Attwell D, Barbour B, Szatkowski M: Nonvesicular release of neurotransmitter. Neuron 1993;375:645-653.
38. Zhao Z, Moghadasian MH: Chemistry, natural sources, dietary intake and pharmacokinetic properties of ferulic acid: a review. Food Chem 2008;109:691-702.
39. Chang MX, Xu LY, Tao JS: Researchs on the matabolism and pharmacokinetics of Ferulic acid in rats. Chin Pharm J 1993; 18:300-300.
40. Hsieh MT, Tsai FH, Lin YC, Wang WH, Wu CR: Effects of ferulic acid on the impairment of inhibitory avoidance performance in rats. Planta Med 2002;68:754-756.
41. Cheng CY, Ho TY, Lee EJ, Su SY, Tang NY, Hsieh CL: Ferulic acid reduces cerebral infarct through its antioxidative and anti-inflammatory effects following transient focal cerebral ischemia in rats. Am J Chin Med 2008;36:1105-1119.
42. Kanski J, Aksenova M, Stoyanova A, Butterfield DA: Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J Nutr Biochem 2002;13:273-281. (Pubitemid 34556688)
43. Choi DW, Rothman SM: The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990; 13:171-182. (Pubitemid 20100647)
44. Meldrum B, Garthwaite J: Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 1990;11: 379-387. (Pubitemid 20262465)